Status:
COMPLETED
Cocarnit Effects on Macrophages Polarization
Lead Sponsor:
Institute for Atherosclerosis Research, Russia
Conditions:
Diabetes Mellitus, Type 2
Diabetes Complications
Eligibility:
All Genders
Phase:
NA
Brief Summary
Cocarnit is a metabolic complex containing disodium adenosine triphosphate trihydrate, cocarboxylase, cyanocobalamin and nicotinamide. Aim: To test the effects of Cocarnit on pro- and anti-inflammato...
Detailed Description
Diabetes mellitus (DM) is the most common endocrine disease, and its social significance is associated with early disability and high mortality. Indicators of diabetes mellitus decompensation are its ...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus newly-diagnosed (for group 1)
- Type 2 diabetes and diabetic polyneuropathy (for group 2)
- Availability of informed consent to participate in the study
Exclusion
- Refusal to sign informed consent to participate in the study
- Presence of chronic diseases that require constant medication, except preparations for the correction of diabetes
- Individual intolerance to the preparation
- Infectious disease or fever during the period of inclusion
- Refusal to take the preparation during the study
- Non-compliance with inclusion criteria
Key Trial Info
Start Date :
October 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03877523
Start Date
October 3 2018
End Date
December 20 2018
Last Update
March 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Atherosclerosis Research
Moscow, Russia, 121609